119 related articles for article (PubMed ID: 37609256)
81. SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.
Du Y; Hou G; Zhang H; Dou J; He J; Guo Y; Li L; Chen R; Wang Y; Deng R; Huang J; Jiang B; Xu M; Cheng J; Chen GQ; Zhao X; Yu J
Nucleic Acids Res; 2018 Jun; 46(10):5195-5208. PubMed ID: 29506078
[TBL] [Abstract][Full Text] [Related]
82. RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation.
Kim JH; Jang JW; Lee YS; Lee JW; Chi XZ; Li YH; Kim MK; Kim DM; Choi BS; Kim J; Kim HM; van Wijnen A; Park I; Bae SC
Oncogenesis; 2014 Apr; 3(4):e101. PubMed ID: 24777122
[TBL] [Abstract][Full Text] [Related]
83. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.
Lin HY; Liu YS; Huang CY; Cathomas F; Liu K; Wang J; Cheng HT; Lai SW; Liu YC; Chen CJ; Lin C; Lu DY
Psychoneuroendocrinology; 2020 Oct; 120():104800. PubMed ID: 32688147
[TBL] [Abstract][Full Text] [Related]
84. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
85. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
Nishida T; Yasuda H
J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
[TBL] [Abstract][Full Text] [Related]
86. DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus.
Zhao L; Zhao Y; Liu Q; Huang J; Lu Y; Ping J
Microbiol Spectr; 2022 Jun; 10(3):e0109822. PubMed ID: 35583334
[TBL] [Abstract][Full Text] [Related]
87. PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.
Kadaré G; Toutant M; Formstecher E; Corvol JC; Carnaud M; Boutterin MC; Girault JA
J Biol Chem; 2003 Nov; 278(48):47434-40. PubMed ID: 14500712
[TBL] [Abstract][Full Text] [Related]
88. N6-methyladenosine reader YTHDF2 promotes multiple myeloma cell proliferation through EGR1/p21
Liu R; Miao J; Jia Y; Kong G; Hong F; Li F; Zhai M; Zhang R; Liu J; Xu X; Wang T; Liu H; Hu J; Yang Y; He A
Oncogene; 2023 May; 42(20):1607-1619. PubMed ID: 37012388
[TBL] [Abstract][Full Text] [Related]
89. Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus.
Yang YC; Yoshikai Y; Hsu SW; Saitoh H; Chang LK
J Biol Chem; 2013 May; 288(18):12866-79. PubMed ID: 23504328
[TBL] [Abstract][Full Text] [Related]
90. Novel prognostic implications of YTH domain family 2 in resected hepatocellular carcinoma.
Nakagawa N; Sonohara F; Tanaka K; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Oncol Lett; 2021 Jul; 22(1):538. PubMed ID: 34084217
[TBL] [Abstract][Full Text] [Related]
91. PIAS1 Promotes Lymphomagenesis through MYC Upregulation.
Rabellino A; Melegari M; Tompkins VS; Chen W; Van Ness BG; Teruya-Feldstein J; Conacci-Sorrell M; Janz S; Scaglioni PP
Cell Rep; 2016 Jun; 15(10):2266-2278. PubMed ID: 27239040
[TBL] [Abstract][Full Text] [Related]
92. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
93. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
94. SUMO Modification Stabilizes Dengue Virus Nonstructural Protein 5 To Support Virus Replication.
Su CI; Tseng CH; Yu CY; Lai MMC
J Virol; 2016 May; 90(9):4308-4319. PubMed ID: 26889037
[TBL] [Abstract][Full Text] [Related]
95.
Varier RA; Sideri T; Capitanchik C; Manova Z; Calvani E; Rossi A; Edupuganti RR; Ensinck I; Chan VWC; Patel H; Kirkpatrick J; Faull P; Snijders AP; Vermeulen M; Ralser M; Ule J; Luscombe NM; van Werven FJ
Elife; 2022 Nov; 11():. PubMed ID: 36422864
[No Abstract] [Full Text] [Related]
96. A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis.
Dadakhujaev S; Salazar-Arcila C; Netherton SJ; Chandhoke AS; Singla AK; Jirik FR; Bonni S
Oncoscience; 2014; 1(3):229-40. PubMed ID: 25594015
[TBL] [Abstract][Full Text] [Related]
97. YTHDF2/m
Zhang L; Dou X; Zheng Z; Ye C; Lu TX; Liang HL; Wang L; Weichselbaum RR; He C
EMBO J; 2023 Aug; 42(15):e113126. PubMed ID: 37345898
[TBL] [Abstract][Full Text] [Related]
98. Understanding YTHDF2-mediated mRNA Degradation By m
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
ArXiv; 2024 Jan; ():. PubMed ID: 38292306
[TBL] [Abstract][Full Text] [Related]
99. Epitranscriptomic Reader YTHDF2 Regulates SEK1(
Malovic E; Ealy A; Hsu PJ; Sarkar S; Miller C; Rokad D; Goeser C; Hartman AK; Zhu A; Palanisamy B; Zenitsky G; Jin H; Anantharam V; Kanthasamy A; He C; Kanthasamy AG
bioRxiv; 2024 Jan; ():. PubMed ID: 38328119
[TBL] [Abstract][Full Text] [Related]
100. YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer.
Jin H; Chen Y; Zhang D; Lin J; Huang S; Wu X; Deng W; Huang J; Yao Y
iScience; 2024 Jun; 27(6):109902. PubMed ID: 38812540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
